Next Article in Journal
Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE Study
Previous Article in Journal
From Bench to Bladder: The Rise in Immune Checkpoint Inhibition in the Treatment of Non-Muscle Invasive Bladder Cancer
 
 
Article

Article Versions Notes

Cancers 2025, 17(7), 1136; https://doi.org/10.3390/cancers17071136
Action Date Notes Link
article xml file uploaded 28 March 2025 10:59 CET Original file -
article xml uploaded. 28 March 2025 10:59 CET Update -
article pdf uploaded. 28 March 2025 10:59 CET Version of Record https://www.mdpi.com/2072-6694/17/7/1136/pdf-vor
article supplementary file uploaded. 28 March 2025 10:59 CET - https://www.mdpi.com/2072-6694/17/7/1136#supplementary
article html file updated 28 March 2025 11:00 CET Original file -
article xml file uploaded 7 April 2025 08:07 CEST Update -
article xml uploaded. 7 April 2025 08:07 CEST Update https://www.mdpi.com/2072-6694/17/7/1136/xml
article pdf uploaded. 7 April 2025 08:07 CEST Updated version of record https://www.mdpi.com/2072-6694/17/7/1136/pdf
article html file updated 7 April 2025 08:09 CEST Update -
article html file updated 24 June 2025 22:08 CEST Update -
article html file updated 28 August 2025 06:58 CEST Update https://www.mdpi.com/2072-6694/17/7/1136/html
Back to TopTop